The Regulatory Challenges for Drug Repurposing During the Covid-19 Pandemic: The Italian Experience
Front Pharmacol
.
2020 Sep 25:11:588132.
doi: 10.3389/fphar.2020.588132.
eCollection 2020.
Authors
Lucia Gozzo
1
,
Laura Longo
1
,
Daniela Cristina Vitale
1
,
Filippo Drago
1
2
Affiliations
1
Clinical Pharmacology Unit, Regional Pharmacovigilance Centre, University Hospital of Catania, Catania, Italy.
2
Department of Biomedical and Biotechnological Sciences, University of Catania, Catania, Italy.
PMID:
33101042
PMCID:
PMC7546760
DOI:
10.3389/fphar.2020.588132
No abstract available
Keywords:
COVID19; Italian regulatory system; drug repurposing; emergency law; off-label.